The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
暂无分享,去创建一个
Brian Olshansky | Arjun D. Sharma | M. Brodsky | H. Greene | B. Olshansky | G. Feld | E. Platia | A. Warner | T. Akiyama | L. Rosenfeld | Toshio Akiyama | Gregory K Feld | Lynda E Rosenfeld | Alberta L Warner | Allen J Solomon | Gearoid O'Neill | Arjun Sharma | Edward Platia | Michael A Brodsky | H Leon Greene | A. Solomon | G. O’Neill | Affirm Investigators | Arjun D Sharma
[1] Bramahn . Singh,et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.
[2] T. Sacchi,et al. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone. , 2001, Chest.
[3] P. Held,et al. Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation—a randomized, placebo‐controlled study , 1999, Clinical cardiology.
[4] P. Probst,et al. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. , 1975, The American journal of cardiology.
[5] J. McMurray,et al. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.
[6] D. Wyse. The AFFIRM Trial: Main Trial and Substudies—What Can We Expect? , 2004, Journal of Interventional Cardiac Electrophysiology.
[7] D M Mirvis,et al. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. , 1991, Journal of the American College of Cardiology.
[8] R. Falk. Pharmacologic control of heart rate in atrial fibrillation. , 1996, Cardiology clinics.
[9] M. Brodsky,et al. Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation. , 1996, Archives of internal medicine.
[10] S. Holgate,et al. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation. , 1988, Clinical science.
[11] R. Beasley,et al. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. , 1985, British medical journal.
[12] A. Redfors. Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation. , 2009, Acta medica Scandinavica.
[13] L. Rydén,et al. Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamil☆ , 1990 .
[14] Marlene R. Miller,et al. The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.
[15] A. R. Rivera,et al. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. , 1997, Annals of emergency medicine.
[16] U. Elkayam,et al. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. , 1986, Circulation.
[17] J. Ronan,et al. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. , 1984, American heart journal.
[18] L. Rydén,et al. Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation. , 1992, American heart journal.
[19] A. Verma,et al. Effects of rhythm regularization and rate control in improving left ventricular function in atrial fibrillation patients undergoing atrioventricular nodal ablation. , 2001, The Canadian journal of cardiology.
[20] P A Poole-Wilson,et al. Six minute walking test for assessing exercise capacity in chronic heart failure. , 1986, British medical journal.
[21] T. Moreland,et al. A comparison of verapamil and digoxin in the treatment of atrial fibrillation. , 1987, European heart journal.
[22] S. Hohnloser,et al. Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial , 2000, The Lancet.
[23] P. H. Beadle,et al. Baseline characteristics of patients with atrial fibrillation: The AFFIRM Study , 2002 .
[24] Sang Joon Park,et al. Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation , 1995 .
[25] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[26] V. Froelicher,et al. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation. , 1987, Journal of the American College of Cardiology.
[27] E. Kaplinsky,et al. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. , 1983, Chest.
[28] K. Ellenbogen,et al. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter. , 1995, The American journal of cardiology.
[29] D. Singer,et al. Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996. , 1998, Archives of internal medicine.
[30] K. Ellenbogen. Role of calcium antagonists for heart rate control in atrial fibrillation. , 1992, The American journal of cardiology.
[31] J. Steinberg,et al. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise. , 1987, Journal of the American College of Cardiology.
[32] M. Gheorghiade,et al. Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing? , 1992, American heart journal.
[33] E. Kaplinsky,et al. Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study. , 1983, American heart journal.
[34] S. Ravid,et al. The effect of atrial fibrillation and the ventricular rate control on exercise capacity , 1997, Clinical cardiology.
[35] S. Walker,et al. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study , 2001, Heart.
[36] Affirm Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. , 2003, Journal of the American College of Cardiology.
[37] K. Koh,et al. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. , 1995, International journal of cardiology.